• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤干细胞肿瘤模型揭示侵袭形态和增加表型异质性。

Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity.

机构信息

Computational Science, Faculty of Science, University of Amsterdam, Amsterdam, the Netherlands.

出版信息

Cancer Res. 2010 Jan 1;70(1):46-56. doi: 10.1158/0008-5472.CAN-09-3663.

DOI:10.1158/0008-5472.CAN-09-3663
PMID:20048071
Abstract

The recently developed concept of cancer stem cells (CSC) sheds new light on various aspects of tumor growth and progression. Here, we present a mathematical model of malignancies to investigate how a hierarchical organized cancer cell population affects the fundamental properties of solid malignancies. We establish that tumors modeled in a CSC context more faithfully resemble human malignancies and show invasive behavior, whereas tumors without a CSC hierarchy do not. These findings are corroborated by in vitro studies. In addition, we provide evidence that the CSC model is accompanied by highly altered evolutionary dynamics compared with the ones predicted to exist in a stochastic, nonhierarchical tumor model. Our main findings indicate that the CSC model allows for significantly higher tumor heterogeneity, which may affect therapy resistance. Moreover, we show that therapy which fails to target the CSC population is not only unsuccessful in curing the patient, but also promotes malignant features in the recurring tumor. These include rapid expansion, increased invasion, and enhanced heterogeneity.

摘要

最近提出的癌症干细胞 (CSC) 概念为肿瘤生长和进展的各个方面提供了新的视角。在这里,我们构建了一个描述恶性肿瘤的数学模型,用于研究分层组织的癌细胞群体如何影响实体恶性肿瘤的基本特性。我们发现,在 CSC 环境下建模的肿瘤更能真实地模拟人类恶性肿瘤,并表现出侵袭性行为,而没有 CSC 层次结构的肿瘤则不会。这些发现得到了体外研究的证实。此外,我们提供的证据表明,与预测存在于随机、非分层肿瘤模型中的进化动力学相比,CSC 模型的进化动力学发生了高度改变。我们的主要发现表明,CSC 模型允许更高的肿瘤异质性,这可能会影响治疗效果。此外,我们还表明,未能针对 CSC 群体进行治疗不仅不能成功治愈患者,而且还会促进复发性肿瘤中的恶性特征,包括快速增殖、侵袭性增强和异质性增加。

相似文献

1
Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity.肿瘤干细胞肿瘤模型揭示侵袭形态和增加表型异质性。
Cancer Res. 2010 Jan 1;70(1):46-56. doi: 10.1158/0008-5472.CAN-09-3663.
2
Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors.对具有层次结构的肿瘤中的表观遗传突变的进化动力学进行建模。
PLoS Comput Biol. 2011 May;7(5):e1001132. doi: 10.1371/journal.pcbi.1001132. Epub 2011 May 5.
3
Exploring cancer stem cell niche directed tumor growth.探索癌症干细胞龛指导肿瘤生长。
Cell Cycle. 2010 Apr 15;9(8):1472-9. doi: 10.4161/cc.9.8.11198.
4
Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts.癌细胞亚群之间的动力学关系揭示了一个与层次和随机概念相协调的模型。
PLoS One. 2014 Jan 9;9(1):e84654. doi: 10.1371/journal.pone.0084654. eCollection 2014.
5
Cancer stem cells and human malignant melanoma.癌症干细胞与人类恶性黑色素瘤
Pigment Cell Melanoma Res. 2008 Feb;21(1):39-55. doi: 10.1111/j.1755-148X.2007.00427.x.
6
A versatile mathematical work-flow to explore how Cancer Stem Cell fate influences tumor progression.一种通用的数学工作流程,用于探索癌症干细胞命运如何影响肿瘤进展。
BMC Syst Biol. 2015;9 Suppl 3(Suppl 3):S1. doi: 10.1186/1752-0509-9-S3-S1. Epub 2015 Jun 1.
7
Strategies for cancer stem cell elimination: insights from mathematical modeling.癌症干细胞消除策略:数学建模的启示。
J Theor Biol. 2012 Apr 7;298:32-41. doi: 10.1016/j.jtbi.2011.12.016. Epub 2011 Dec 23.
8
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.癌症干细胞异质性:起源及针对癌症干细胞的新观点
BMB Rep. 2017 Mar;50(3):117-125. doi: 10.5483/bmbrep.2017.50.3.222.
9
Cancer stem cells: a guide for skeptics.癌症干细胞:怀疑者指南
J Cell Biochem. 2009 Apr 1;106(5):745-9. doi: 10.1002/jcb.22050.
10
Cancer stem cells in breast cancer and metastasis.乳腺癌中的癌症干细胞与转移
Breast Cancer Res Treat. 2009 Nov;118(2):241-54. doi: 10.1007/s10549-009-0524-9.

引用本文的文献

1
Cancer stem cells: Bridging microenvironmental interactions and clinical therapy.癌症干细胞:连接微环境相互作用与临床治疗
Clin Transl Med. 2025 Jul;15(7):e70406. doi: 10.1002/ctm2.70406.
2
Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities.癌症干细胞与免疫疗法的关联:关键见解、挑战及潜在治疗机遇
Cancers (Basel). 2025 Jun 23;17(13):2100. doi: 10.3390/cancers17132100.
3
Asymmetric cell division of ALDH1-positive cancer stem cells generates glycolytic metabolically diverse cell populations.
醛脱氢酶1阳性癌症干细胞的不对称细胞分裂产生糖酵解代谢多样化的细胞群体。
Sci Rep. 2025 Apr 22;15(1):13932. doi: 10.1038/s41598-025-97985-2.
4
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.哺乳动物癌症干细胞耐药性的综合综述:对癌症治疗的启示
Cancer Cell Int. 2024 Dec 18;24(1):406. doi: 10.1186/s12935-024-03558-0.
5
Evolutionary rescue model informs strategies for driving cancer cell populations to extinction.进化救援模型为促使癌细胞群体灭绝的策略提供了依据。
bioRxiv. 2025 Jan 13:2024.11.26.625315. doi: 10.1101/2024.11.26.625315.
6
CAV1 inhibits Xc system through IFNGR1 to promote ferroptosis to inhibit stemness and improves anti-PD-1 efficacy in breast cancer.CAV1通过IFNGR1抑制Xc系统,以促进铁死亡从而抑制干性,并提高乳腺癌中抗PD - 1的疗效。
Transl Oncol. 2024 Dec;50:102149. doi: 10.1016/j.tranon.2024.102149. Epub 2024 Oct 11.
7
Modulatory Effect of Vitamin C on Hypoxia Induced Breast Cancer Stem Cells.维生素C对缺氧诱导的乳腺癌干细胞的调节作用。
Adv Pharm Bull. 2023 Nov;13(4):792-798. doi: 10.34172/apb.2023.073. Epub 2023 Feb 21.
8
Engineering Heterogeneous Tumor Models for Biomedical Applications.工程化异质肿瘤模型用于生物医学应用。
Adv Sci (Weinh). 2024 Jan;11(1):e2304160. doi: 10.1002/advs.202304160. Epub 2023 Nov 9.
9
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.癌症干细胞中的调控和信号通路:对癌症靶向治疗的启示。
Mol Cancer. 2023 Oct 18;22(1):172. doi: 10.1186/s12943-023-01877-w.
10
Therapeutic potential of pentamidine for glioma-initiating cells and glioma cells through multimodal antitumor effects.戊二脒通过多种抗肿瘤作用对神经胶质瘤起始细胞和神经胶质瘤细胞的治疗潜力。
Cancer Sci. 2023 Jul;114(7):2920-2930. doi: 10.1111/cas.15827. Epub 2023 May 4.